Literature DB >> 3026840

CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis. Relationship to vasoactive intestinal polypeptide.

M R Ruff, B M Martin, E I Ginns, W L Farrar, C B Pert.   

Abstract

The octapeptide Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr (peptide T) and two structural analogs are potent agonists of human monocyte chemotaxis, evincing identical rank potency orders as was previously shown for their inhibition of human immunodeficiency virus (HIV) envelope binding and T cell infectivity. Chemotactic activity could be inhibited by anti-CD4 monoclonal antibodies (Mabs), but not other mononuclear cell Mabs. The core peptide required for chemotactic activity is a pentapeptide related to the sequence Thr-Thr-Asn-Tyr-Thr. Homologous pentapeptides, identified by computer search, were detected in several other non-HIV-related viruses as well as the neuropeptide vasoactive intestinal polypeptide (VIP). The CD4 molecule, therefore, appears to be a recognition molecule for a small signal peptide ligand whose active sequence is a homolog of peptide T and which may be the neuropeptide VIP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026840     DOI: 10.1016/0014-5793(87)81265-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats.

Authors:  I Sáez-Torres; C Espejo; J J Pérez; N Acarín; X Montalban; E M Martínez-Cáceres
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 2.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

3.  HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting.

Authors:  S E Mulroney; K J McDonnell; C B Pert; M R Ruff; Z Resch; W K Samson; M D Lumpkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Chemotactic response of human monocytes to pentapeptide analog derived from immunodeficiency virus protein gp 120.

Authors:  S Spisani; R Gavioli; A L Giuliani; T Cavalletti; M Marastoni; G Balboni; S Salvadori; R Tomatis; S Traniello
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

5.  A proposed bioactive conformation of peptide T.

Authors:  N B Centeno; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1998-01       Impact factor: 3.686

6.  Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment.

Authors:  T Talme; B L Rozell; K G Sundqvist; L Wetterberg; J A Marcusson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 7.  Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis.

Authors:  H Budka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum.

Authors:  M F Powell; T Stewart; L Otvos; L Urge; F C Gaeta; A Sette; T Arrhenius; D Thomson; K Soda; S M Colon
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

Review 9.  VIP: molecular biology and neurobiological function.

Authors:  I Gozes; D E Brenneman
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

10.  Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy.

Authors:  F Gray; H Haug; L Chimelli; C Geny; A Gaston; F Scaravilli; H Budka
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.